GlennJaffeMD
Ophthalmology • Durham, NCCataract Related, Retinal Disease, Uveitis
Professor, Ophthalmology, Duke University School of Medicine
Dr. Jaffe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467Fax+1 919-681-6474
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1987 - 1989
University of California (San Francisco)Residency, Ophthalmology, 1984 - 1987- University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1983 - 1984
- University of California San Francisco School of MedicineClass of 1983
Certifications & Licensure
NC State Medical License 1989 - 2025
WI State Medical License 1987 - 1989- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment Start of enrollment: 2004 Mar 01
- Retisert and Cataract Surgery in Patients With Severe Uveitis Start of enrollment: 2006 Sep 01
- Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 111 citationsGrowth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.Juan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, Maureen G Maguire, Ebenezer Daniel
Ophthalmology. 2015-04-01 - 488 citationsFive-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degene...Maureen G. Maguire, Daniel F. Martin, Gui-Shuang Ying, Glenn J. Jaffe, Ebenezer Daniel
Ophthalmology. 2016-08-01 - 2004 citationsRanibizumab and bevacizumab for neovascular age-related macular degeneration.Daniel F. Martin, Maureen G. Maguire, Gui-Shuang Ying, Juan E. Grunwald, Stuart L. Fine
The New England Journal of Medicine. 2011-05-19
Journal Articles
- Development, Validation, and Innovation in Ophthalmic Laser-Based ImagingFrank Brodie, Natalie Afshari, Jennifer E Thorne, Albert Vitale, David Myung, Mark S Blumenkranz, Elmer Tu, David Sarraf, Glenn J Jaffe, Malvina Eydelman, JAMA Ophthalmology
- Development, Validation, and Innovation in Ophthalmic Laser-Based ImagingFrank Brodie, Natalie Afshari, Jennifer E Thorne, Albert Vitale, David Myung, Mark S Blumenkranz, Elmer Tu, David Sarraf, Glenn J Jaffe, Malvina Eydelman, JAMA Ophthalmology
- Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical TrialGlenn Jaffe, MD, JAMA Ophthalmology
- Join now to see all
Press Mentions
LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve VisionNovember 4th, 2024- Researchers Discover Therapeutic Target to Aid in Glaucoma TreatmentMarch 16th, 2023
- LumiThera Announces Sustained Vision Improvement for 24 Months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial DataMarch 15th, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
